disease-prevention

Documents about disease-prevention

• HHSD200201792968C — MCKESSON SPECIALTY DISTRIBUTION LLC — Department of Health and Human Services ($1,095,821,732)#605063USAspending
• HHSD200200615819C — MERCK SHARP & DOHME CORP. — Department of Health and Human Services ($1,035,982,833)#605122USAspending
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11947DataCite
• Developing an AI-Based Visual Decision Support System: A Patient-Centered Perspective for Early Neurological Disease Detection and Prevention – Insights from Alzheimer's Disease and Related Dementia#11948DataCite
• Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model#264625Apollo
• The RISC Registry--Risk Informed Screening Registry#913892ClinicalTrials.gov
• Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016#679275OpenAlex
• Chronic kidney disease awareness, prevention and policy gaps with implications for the Nigerian Navy: a scoping review#314113African Journals Online
• A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease#881656ClinicalTrials.gov
• Evaluation of Ventilation Homogeneity as a Marker of Small Airway Disease in Active Smokers#889271ClinicalTrials.gov
• Synergistic Effects of Medical Plants on Probiotics and Their Applications in Poultry Nutrition#68173Zenodo (CERN)
• Implementation of Personalized Precision Medicine: Expanding the Clinical Vision towards Prevention, Early Detection and Precision Treatment of Disease to Drive Extended Healthspan#94310PhilArchive
• Global Effect of Cardiovascular Risk Factors on Lifetime Estimates#147600HAL (France)
• The Potential Effect of Ending Centers for Disease Control and Prevention Funding for HIV Tests: A Modeling Study in 18 States.#148416NCBI PubMed Central
• Hook System Concept Development#204980Borealis Dataverse OAI Archive
• Prevalence and determinants of workplace loneliness in Germany. A cross-sectional study#219895Springer Nature OA
• Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine#234489ClinicalTrials.gov
• Hepatitis B in Africa Collaborative Network : cohort profile and analysis of baseline data#248625SUNScholar
• The Underestimated Role of Environmental Factors in the Prevention of Invasive Fungal Disease: Experience From a European Childhood Cancer Centre.#323226NCBI PubMed Central
• A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects#332802ClinicalTrials.gov
• A Study of TAK-019 in Healthy Japanese Adults (COVID-19)#353348ClinicalTrials.gov
• Integrating Policies that Enable Minimally Processed Foods with Policies that Restrict Ultra-Processed Foods for Obesity and Noncommunicable Disease Prevention.#364757NCBI PubMed Central
• Building on the Doha Declaration: a white paper on advancing lifestyle medicine for non-communicable disease prevention and health system transformation.#392652NCBI PubMed Central
• Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine#394625ClinicalTrials.gov
• Role of minerals in disease prevention, pollution control, and productivity in chickens: review#443677Springer Nature OA
• Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda#633753ClinicalTrials.gov
• Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease#811996ClinicalTrials.gov
• Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina#857881ClinicalTrials.gov
• Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)#866464ClinicalTrials.gov
• Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)#870050ClinicalTrials.gov
• 75D30120F09856 — LOYAL SOURCE GOVERNMENT SERVICES LLC — Department of Health and Human Services ($62,674,168)#601539USAspending
• 75D30125F00225 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($29,975,589)#602146USAspending
• 75D30123F18094 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($26,999,724)#602300USAspending
• 75D30126F20900 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($26,415,767)#602335USAspending
• 75D30125F00222 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($26,088,296)#602361USAspending
• 75D30126F20922 — DELL FEDERAL SYSTEMS L.P — Department of Health and Human Services ($24,999,040)#602416USAspending
• Evaluation of the Effectiveness and Implementation of the BETTER Women Peer Health Coaching Program#838618ClinicalTrials.gov
• Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant#981826ClinicalTrials.gov
• West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions#4731Europe PMC
• West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions.#9764PubMed
• Social Vulnerability Index (SVI) 2018-2022#120839DataCite
• Cutaneous Leishmaniasis in Tigray, North Ethiopia: The Communities’ Awareness, Perceptions, Treatment-seeking and Prevention Practices in Disease Endemic Areas#138335Unpaywall
• An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment#154686ClinicalTrials.gov
• Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)#174933ClinicalTrials.gov
• 2.0 Slider 3D Models#204947Borealis Dataverse OAI Archive
• 2.0 Development and Design#204950Borealis Dataverse OAI Archive
• 1.0 Slider 3D Models#204963Borealis Dataverse OAI Archive
• 2.0 Slider Photos & Video#204965Borealis Dataverse OAI Archive
• 1.0 Slider Photos & Video#204968Borealis Dataverse OAI Archive
• Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)#226338ClinicalTrials.gov